[HTML][HTML] Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang… - Signal transduction and …, 2021 - nature.com
The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback …

[HTML][HTML] Small molecules in the treatment of COVID-19

S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

[HTML][HTML] Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection

Y Yi, J Li, X Lai, M Zhang, Y Kuang, YO Bao… - Journal of advanced …, 2022 - Elsevier
Introduction The COVID-19 global epidemic caused by severe acute respiratory syndrome
coronavirus (SARS-CoV-2) is a great public health emergency. Discovering antiviral drug …

[HTML][HTML] Phytochemicals as invaluable sources of potent antimicrobial agents to combat antibiotic resistance

R Jadimurthy, S Jagadish, SC Nayak, S Kumar… - Life, 2023 - mdpi.com
Simple Summary Many microorganisms develop resistance to drugs through different
mechanisms, and this process is called antimicrobial resistance. It is highly essential to …

[HTML][HTML] Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines

L Guo, S Lin, Z Chen, Y Cao, B He, G Lu - Signal Transduction and …, 2023 - nature.com
The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused devastating impacts …

[HTML][HTML] Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry

D Zhang, S Hamdoun, R Chen, L Yang, CK Ip… - Pharmacological …, 2021 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), which enter the host cells through the interaction …

[HTML][HTML] Recent advances in developing small-molecule inhibitors against SARS-CoV-2

R Xiang, Z Yu, Y Wang, L Wang, S Huo, Y Li… - … Pharmaceutica Sinica B, 2022 - Elsevier
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across
the entire world. Even though several COVID-19 vaccines are currently in distribution …

[HTML][HTML] Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products

CL He, LY Huang, K Wang, CJ Gu, J Hu… - Signal transduction and …, 2021 - nature.com
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a major public health issue. The spike (S) protein mutation …

[HTML][HTML] Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19

Y Yi, M Zhang, H Xue, R Yu, YO Bao, Y Kuang… - … Pharmaceutica Sinica B, 2022 - Elsevier
It is an urgent demand worldwide to control the coronavirus disease 2019 (COVID-19)
pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal

K Nepali, R Sharma, S Sharma, A Thakur… - Journal of Biomedical …, 2022 - Springer
Unprecedented efforts of the researchers have been witnessed in the recent past towards
the development of vaccine platforms for the control of the COVID-19 pandemic. Albeit …